Avalo Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.

About AVTX

Avalo Therapeutics, Inc. is a biopharmaceutical company. engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation. 

CEO
Garry Arthur Neil
CEOGarry Arthur Neil
Employees
44
Employees44
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2011
Founded2011
Employees
44
Employees44

AVTX Key Statistics

Market cap
32.67M
Market cap32.67M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
13.12K
Average volume13.12K
High today
$3.47
High today$3.47
Low today
$3.08
Low today$3.08
Open price
$3.08
Open price$3.08
Volume
731.00
Volume731.00
52 Week high
$30.00
52 Week high$30.00
52 Week low
$2.42
52 Week low$2.42

AVTX Earnings

-$3.84
-$2.56
-$1.28
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.